Johnson & Johnson (JNJ) Stock Chart

NYSE
$253.90-0.01 (-0.01%)After hours

View the Johnson & Johnson stock chart with market data, key statistics, volume, financial metrics, latest news, and exportable historical data.

Source
Delayed Quote
Quote Time
Oct 14, 2026, 8:36 PM UTC
Delay
20 min source-reported delay

Market data is for research and educational use only, not investment advice. Quotes may be delayed depending on the source and exchange; verify important prices with your broker or data provider.

Read the JNJ trend first

Use the range controls to compare short-term moves with the longer-term Johnson & Johnson stock chart. A move that looks large on 1D can look routine on a 1Y or 5Y chart.

Check price with volume

Volume helps show whether a move happened with broad participation or thin trading. Compare recent bars with the average volume and news context before drawing conclusions.

Verify before acting

This page is built for research and education. Quotes, analyst fields, and news can be delayed or revised, so verify important prices with your broker or primary data provider.

Key Statistics

Previous Close$248.61
Open$249.10
Day Range$248.79 — $253.94
52 Wk Range$184.66 — $281.07
Volume9,644,746
Avg Volume7,131,659
Market Cap611.90B
P/E (TTM)29.42
P/E (Fwd)21.64
EPS (TTM)$8.63
Dividend Yield2.16%
Beta0.21
50 Day Avg$265.37
200 Day Avg$243.41
Shares Out2.41B
PEG Ratio2.64
Price/Book7.50

Financial Metrics

Revenue
97.93B
Revenue Growth
6.60%
Gross Margin
68.14%
Operating Margin
29.19%
Profit Margin
21.48%
Return on Equity
25.74%
Total Cash
20.76B
Total Debt
49.04B
Free Cash Flow
16.89B
Analyst Target
$279.14
Analyst Consensus
Buy
Analyst Opinions
22

About Johnson & Johnson

Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
138,200
Headquarters
New Brunswick, NJ, United States
Website
jnj.com
CEO
Mr. Joaquin Duato

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Related Charts

Data Definitions

Previous close

The most recent prior regular-session close reported by the market data source.

Day range

The source-reported high and low for the current or most recent trading session.

Volume

The number of shares, units, contracts, or asset quantity reported as traded during the period.

Moving averages

The 50-day and 200-day averages smooth recent prices to give quick trend context.

Market cap

A company or fund size estimate based on price and shares outstanding when source data is available.

P/E ratio

Price divided by earnings per share. It is most useful when compared with peers and growth expectations.